GAMMA Investing’s Ambrx Biopharma Inc AMAM Stock Holding History

GAMMA Investing’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-491	Closed	-$13.7K	–	3388
2023 Q4	$13.7K	Buy	+491	New	+$5.58K	﹤0.01%	1726

GAMMA Investing's AMAM Position: Q1 2024 in Review

GAMMA Investing sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 491 shares — an estimated $13.7K sold.

GAMMA Investing first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $13.7K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

GAMMA Investing reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
GAMMA Investing sold 491 Ambrx Biopharma Inc shares in Q1 2024, an estimated $13.7K.
GAMMA Investing first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
GAMMA Investing's Ambrx Biopharma Inc position peaked at $13.7K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on GAMMA Investing's 13F filing for Q1 2024, filed 5 Apr 2024.